Candel Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for CADL

Based on 3 analysts offering 12 month price targets for Candel Therapeutics Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell CADL stock?

Based on 3 analysts offering ratings for Candel Therapeutics Inc.
Strong Buy
0 analysts 0%
3 analysts 100%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CADL stock forecasts and price targets.

CADL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 16%
BMO Capital
Top 43%
Credit Suisse
Top 15%

1 of 1

CADL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNSE$1.41$6.00+325.53%Strong Buy

Candel Therapeutics Stock Forecast FAQ

Is Candel Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CADL) stock is to Buy CADL stock.

Out of 3 analysts, 0 (0%) are recommending CADL as a Strong Buy, 3 (100%) are recommending CADL as a Buy, 0 (0%) are recommending CADL as a Hold, 0 (0%) are recommending CADL as a Sell, and 0 (0%) are recommending CADL as a Strong Sell.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.

What is CADL's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CADL price target, the average CADL price target is $7.00, with the highest CADL stock price forecast at $11.00 and the lowest CADL stock price forecast at $3.00.

On average, Wall Street analysts predict that Candel Therapeutics's share price could reach $7.00 by May 22, 2024. The average Candel Therapeutics stock price prediction forecasts a potential upside of 357.52% from the current CADL share price of $1.53.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.